KR100498288B1 - 핵산 마이크로어레이 및 이의 제조방법 - Google Patents
핵산 마이크로어레이 및 이의 제조방법 Download PDFInfo
- Publication number
- KR100498288B1 KR100498288B1 KR10-2002-0082125A KR20020082125A KR100498288B1 KR 100498288 B1 KR100498288 B1 KR 100498288B1 KR 20020082125 A KR20020082125 A KR 20020082125A KR 100498288 B1 KR100498288 B1 KR 100498288B1
- Authority
- KR
- South Korea
- Prior art keywords
- nucleic acid
- nanoparticles
- microarray
- substrate
- acid microarray
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 225
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 219
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 219
- 238000002493 microarray Methods 0.000 title claims abstract description 124
- 238000004519 manufacturing process Methods 0.000 title abstract description 16
- 239000002105 nanoparticle Substances 0.000 claims abstract description 78
- 239000000758 substrate Substances 0.000 claims abstract description 51
- 239000000017 hydrogel Substances 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims description 52
- 230000000295 complement effect Effects 0.000 claims description 22
- 239000000499 gel Substances 0.000 claims description 22
- 238000009739 binding Methods 0.000 claims description 20
- 229920002401 polyacrylamide Polymers 0.000 claims description 14
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 11
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 11
- 239000010931 gold Substances 0.000 claims description 11
- 229910052737 gold Inorganic materials 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 11
- 125000003729 nucleotide group Chemical group 0.000 claims description 11
- 108091093037 Peptide nucleic acid Proteins 0.000 claims description 10
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 9
- 239000000178 monomer Substances 0.000 claims description 8
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 claims description 8
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 7
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- 239000011616 biotin Substances 0.000 claims description 5
- 229960002685 biotin Drugs 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- 108010090804 Streptavidin Proteins 0.000 claims description 4
- 150000001408 amides Chemical class 0.000 claims description 4
- 230000003100 immobilizing effect Effects 0.000 claims description 4
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims description 4
- UNEXJVCWJSHFNN-UHFFFAOYSA-N n,n,n',n'-tetraethylmethanediamine Chemical compound CCN(CC)CN(CC)CC UNEXJVCWJSHFNN-UHFFFAOYSA-N 0.000 claims description 4
- 230000000379 polymerizing effect Effects 0.000 claims description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 3
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 3
- 238000006116 polymerization reaction Methods 0.000 claims description 3
- 229960002477 riboflavin Drugs 0.000 claims description 3
- 235000019192 riboflavin Nutrition 0.000 claims description 3
- 239000002151 riboflavin Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- RWHRFHQRVDUPIK-UHFFFAOYSA-N 50867-57-7 Chemical compound CC(=C)C(O)=O.CC(=C)C(O)=O RWHRFHQRVDUPIK-UHFFFAOYSA-N 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000003431 cross linking reagent Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 claims description 2
- 230000003313 weakening effect Effects 0.000 claims description 2
- LLIANSAISVOLHR-GBCQHVBFSA-N 5-[(3as,4s,6ar)-2-oxidanylidene-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 LLIANSAISVOLHR-GBCQHVBFSA-N 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims 1
- 230000005251 gamma ray Effects 0.000 claims 1
- 229920001477 hydrophilic polymer Polymers 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 description 16
- 108020004414 DNA Proteins 0.000 description 15
- 239000011521 glass Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 239000002253 acid Substances 0.000 description 10
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000000636 Northern blotting Methods 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- NOIRDLRUNWIUMX-UHFFFAOYSA-N 2-amino-3,7-dihydropurin-6-one;6-amino-1h-pyrimidin-2-one Chemical compound NC=1C=CNC(=O)N=1.O=C1NC(N)=NC2=C1NC=N2 NOIRDLRUNWIUMX-UHFFFAOYSA-N 0.000 description 2
- FFKUHGONCHRHPE-UHFFFAOYSA-N 5-methyl-1h-pyrimidine-2,4-dione;7h-purin-6-amine Chemical compound CC1=CNC(=O)NC1=O.NC1=NC=NC2=C1NC=N2 FFKUHGONCHRHPE-UHFFFAOYSA-N 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000002073 fluorescence micrograph Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 239000002853 nucleic acid probe Substances 0.000 description 2
- 238000000206 photolithography Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000001338 self-assembly Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- VLEIUWBSEKKKFX-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O VLEIUWBSEKKKFX-UHFFFAOYSA-N 0.000 description 1
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- DKQVJMREABFYNT-UHFFFAOYSA-N ethene Chemical group C=C.C=C DKQVJMREABFYNT-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012775 microarray technology Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000001259 photo etching Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/155—Particles of a defined size, e.g. nanoparticles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (20)
- 기판 상에, 원판 핵산 마이크로어레이 상의 핵산과 상보적 염기 서열을 갖는 핵산을 포함하는 핵산 마이크로어레이로서,상기 원판 핵산 마이크로어레이 상의 핵산과 상보적 염기 서열을 갖는 핵산은 나노 입자와 결합되어 있으며, 상기 나노 입자에 의하여 하이드로겔 내에 고정되어 기판에 결합되어 있는 것이고,원판 핵산 마이크로어레이 상의 핵산과 상보적 염기 서열을 갖는 핵산이 상기 원판 핵산 마이크로어레이 상의 핵산 분자의 공간적 배열과 거울상의 대칭 배열 상태를 유지하면서 고정되어 있는 것을 특징으로 하는 핵산 마이크로어레이.
- 제 1 항에 있어서, 상기 핵산이 각종 DNA, RNA, PNA(Peptide Nucleic Acids), 또는 LNA(Locked Nucleic Acids)와 같이 염기서열 형태로 정보를 가지며 상보적인 염기서열을 포함하는 핵산과 선택적으로 결합할 수 있는 분자인 핵산 마이크로어레이.
- 제 1 항에 있어서, 상기 하이드로 겔이 에틸렌(ethylene)기를 가진 모노머 유니트가 중합 반응하여 만들어진 친수성 고분자인 핵산 마이크로어레이.
- 제 3 항에 있어서, 상기 하이드로 겔의 모노머가 에틸렌기를 가진 폴리머화가 가능한 화합물로서, 아크릴아마이드(acrylamide), 메타크릴아마이드(methacrylamide), 아크릴산(acrylic acid), 메타크릴산 (methacrylic acid), 또는 이들과 구조적으로 연관된 아마이드(amide)나 에스테르(ester)인 핵산 마이크로어레이.
- 제 4 항에 있어서, 상기 하이드로 겔이 폴리아크릴아마이드 겔인 핵산 마이크로어레이.
- 제 1 항에 있어서, 상기 나노입자의 지름이 수 nm 내지 100 nm인 핵산 마이크로어레이.
- 제 1 항에 있어서, 상기 기판이 에틸렌기로 표면 개질된 것인 핵산 마이크로어레이.
- 1) 제작하고자 하는 핵산 마이크로어레이와 상보적인 염기서열을 갖는 핵산이 배열된 원판 핵산 마이크로어레이를 제작하는 단계;2) 상기 원판 핵산 마이크로어레이를 핵산 마이크로어레이를 구성할 핵산이 결합된 나노입자를 포함하는 용액에 담가, 서로 상보적 염기서열을 갖는 원판 핵산 마이크로어레이 상의 핵산과 나노입자 상의 핵산을 혼성화시키는 단계;3) 상기 나노입자가 결합된 원판 핵산 마이크로어레이를 세척하여 비선택적으로 결합된 나노입자를 제거하는 단계;4) 상기 나노입자가 결합된 원판 핵산 마이크로어레이 상에 기판을 대고, 그 사이를 하이드로 겔로 채워, 원판 핵산 마이크로어레이 상의 상보적 염기서열을 갖는 핵산의 공간적 배열과 거울상의 대칭 배열 상태를 유지한 채로 하이드로 겔 내에 나노입자를 고정시키는 단계; 및5) 나노입자가 고정된 하이드로 겔이 고정된 기판을 떼어 내어 복제된 핵산 마이크로어레이를 얻는 단계를 포함하여 이루어지는 핵산 마이크로어레이 제작방법.
- 제 8 항에 있어서, 상기 단계 5) 이후의 원판 핵산 마이크로어레이에 단계 2) 내지 단계 5)의 과정을 반복하는 단계를 추가적으로 포함함으로써, 하나의 원판 핵산 마이크로어레이를 사용하여 다수의 복제된 핵산 마이크로어레이를 제작할 수 있는 방법.
- 제 8 항에 있어서, 상기 핵산으로서 각종 DNA, RNA, PNA(Peptide Nucleic Acids), 또는 LNA(Locked Nucleic Acids)와 같이 염기서열 형태로 정보를 가지며 상보적인 염기서열을 포함하는 핵산과 선택적으로 결합할 수 있는 모든 분자를 사용하는 방법.
- 제 8 항에 있어서, 상기 나노입자로서 지름이 수 nm 내지 100 nm인 것을 사용하는 방법.
- 제 8 항에 있어서, 상기 단계 2)를 나노입자에 스트렙트아비딘(streptavidin)을 고정시키고, 핵산의 끝에 비오틴(biotin)을 결합시켜서, 스트렙트아비딘-비오틴의 강한 결합을 통하여 나노입자에 핵산을 고정시켜서 수행하는 방법.
- 제 8 항에 있어서, 상기 단계 2)를 금(gold) 등과 같이 티올(thiol)기와 결합할 수 있는 금속으로 만든 나노입자 또는 표면이 이들 금속으로 된 나노입자와 티올기가 부착된 핵산을 사용하여, 상기 금속과 핵산의 티올기와의 공유결합을 통하여 나노입자에 핵산을 고정시켜서 수행하는 방법.
- 제 8 항에 있어서, 상기 단계 4)를 에틸렌(ethylene)기를 갖는 중합 가능한 모노머를 포함하는 용액을 원판과 기판 사이에 주입하고, 이들을 중합 반응시켜, 원판과 기판 사이에 친수성 하이드로 겔을 형성시켜서 수행하는 방법.
- 제 14 항에 있어서, 상기 단계 4)를 원판과 기판 사이에 아크릴아마이드(acrylamide), 메타크릴아마이드(methacrylamide), 아크릴산(acrylic acid), 메타크릴산 (methacrylic acid), 또는 이들과 구조적으로 연관된 아마이드(amide)나 에스테르(ester)를 포함하는 용액을 주입하여 친수성 하이드로 겔을 형성시켜서 수행하는 방법.
- 제 15 항에 있어서, 상기 단계 4)를 원판과 기판 사이에 아크릴아마이드(acrylamide) 용액을 넣고 중합반응을 시켜 폴리아크릴아마이드(polyacrylamide) 겔을 형성시켜서 수행하는 방법.
- 제 16 항에 있어서, 상기 형성된 폴리아크릴아마이드 겔의 구조적 강도를 강화시키기 위하여, 이들을 가교시켜 줄 수 있는 비스아크릴아마이드(bisacrylamide)와 같은 가교제를 아크릴아마이드 용액 첨가하고, 이들을 중합반응 시켜서 수행하는 방법.
- 제 14 항에 있어서, 상기 중합 반응을 모노머 용액에 퍼설페이트(persulfate) 및 테트라에틸메틸렌디아민(tetraetylmethylenediamine; TEMED)를 첨가하거나, 퍼설페이트를 첨가하고 가열하거나, 과산화수소 및 Fe2+를 첨가하거나, 리보플라빈(riboflavin)을 첨가하고 가시광선을 조사하거나, 퍼설페이트 및 바이설파이트(bisulfite)를 첨가하거나, 퍼설페이트 및 티오설페이트(thiosulfate)를 첨가하거나, 감마광 조사하여 수행하는 방법.
- 제 8 항에 있어서, 하이드로 겔과 결합이 잘 되도록 하기 위하여 기판의 표면을 에틸렌(ethylene)기로 개질시켜 사용하는 방법.
- 제 8 항에 있어서, 상기 단계 5)의 원판과 기판의 분리 시 핵산-핵산 결합력에 의하여 핵산이 손상되거나 핵산 마이크로어레이에서 떨어지는 것을 방지하기 위하여, 온도를 올려 원판 상의 핵산과 나노입자에 고정된 핵산 사이에 결합을 약화시킨 후 상기 단계 5)를 수행하는 방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0082125A KR100498288B1 (ko) | 2002-12-21 | 2002-12-21 | 핵산 마이크로어레이 및 이의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0082125A KR100498288B1 (ko) | 2002-12-21 | 2002-12-21 | 핵산 마이크로어레이 및 이의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040055441A KR20040055441A (ko) | 2004-06-26 |
KR100498288B1 true KR100498288B1 (ko) | 2005-07-01 |
Family
ID=37348115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2002-0082125A KR100498288B1 (ko) | 2002-12-21 | 2002-12-21 | 핵산 마이크로어레이 및 이의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100498288B1 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100773085B1 (ko) * | 2004-11-25 | 2007-11-02 | 강원대학교산학협력단 | 형질전환 식물체의 유전자의 분석방법 |
KR100832738B1 (ko) * | 2007-01-23 | 2008-05-27 | 포천중문의과대학교 산학협력단 | 펩타이드 핵산 탐침이 고정화된 마이크로어레이를 이용한표적 유전자의 검출 방법 |
KR101293666B1 (ko) * | 2011-03-07 | 2013-08-13 | 고려대학교 산학협력단 | 단백질 나노입자를 이용한 3차원 나노구조체 |
WO2022092651A1 (ko) * | 2020-10-27 | 2022-05-05 | 한국과학기술원 | 핵산을 매개로 한 패턴 복제 및 이를 이용한 이차원 재료 제작 방법 |
-
2002
- 2002-12-21 KR KR10-2002-0082125A patent/KR100498288B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20040055441A (ko) | 2004-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6664061B2 (en) | Use and evaluation of a [2+2] photoaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix | |
Guschin et al. | Manual manufacturing of oligonucleotide, DNA, and protein microchips | |
EP1147222B1 (en) | Replicable probe array | |
Rubina et al. | Hydrogel drop microchips with immobilized DNA: properties and methods for large-scale production | |
EP1307414A2 (en) | The use and evaluation of a 2+2] photocycloaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix | |
US20030211478A1 (en) | Transcription factor profiling on a solid surface | |
JP4184089B2 (ja) | 基板、調製及び使用 | |
JP3883539B2 (ja) | エポキシ基を有する放射状ポリエチレングリコール誘導体を用いたハイドロゲルバイオチップの製造方法 | |
JP2007533983A (ja) | マイクロアレイ用の機能性多孔質支持体 | |
US9266726B2 (en) | Method for making biochips | |
US20030148360A1 (en) | Replicable probe array | |
KR100498288B1 (ko) | 핵산 마이크로어레이 및 이의 제조방법 | |
JP2002122610A (ja) | Dna分析用マイクロアレイの製造方法 | |
US6878523B2 (en) | Molecular interaction assays on a solid surface | |
KR100498289B1 (ko) | 중합 반응을 이용하여 복제된 핵산 마이크로어레이 및이의 제작 방법 | |
JP4137898B2 (ja) | 生体分子を固体基板上に非共有的に固定化する方法及びそれによって製造されるマイクロアレイ | |
KR20030020232A (ko) | 에폭시기를 갖는 방사형 폴리에틸렌글리콜 유도체를이용한 하이드로 젤 바이오칩의 제조방법 | |
JP2004509323A (ja) | 複製可能プローブアレー | |
US20020172960A1 (en) | DNA microarrays of networked oligonucleotides | |
JP2005291952A (ja) | 生体関連物質固定用粒子およびマイクロアレイ | |
KR100487167B1 (ko) | 바이오칩 및 이의 제조방법 | |
JP2003530861A (ja) | オリゴヌクレオチドを支持体に固定させる方法及びその方法によって製造されるオリゴヌクレオチドアレイ | |
JP2007047024A (ja) | 生体関連物質の定量方法 | |
JP2002031637A (ja) | Dna分析素子 | |
JP2005283350A (ja) | 核酸固定化方法及びdnaチップ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20021221 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20041220 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20050427 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20050621 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20050622 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20080319 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20090416 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20100331 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20110328 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20120521 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20130514 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20130514 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140523 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20140523 Start annual number: 10 End annual number: 10 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20160509 |